The structure of major causes of mortality in patients with schizophrenia in Moscow (2007–2013)
Suggested citation:
Shchepin VO, Masyakin AV. [The structure of major causes of mortality in patients with schizophrenia in Moscow (2007–2013)]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2014;(3):57-60. Russian
The author has studied and statistically analyzed the case histories of 296 deceased schizophrenic patients in the archives of psychiatric hospitals in Moscow, covering the period from 2007 to 2013. He describes the somatic morbidity rate at the time of hospital admission, causes of death and age-related characteristics of mortality in schizophrenic patients. It is demonstrated that the most common somatic disorders that lead to death of schizophrenic patients refer to the class of diseases that involve the circulatory system, respiratory diseases and malignant tumors.
1. Волков В.П. Соматическая патология и причины смерти при шизофрении // Журн. неврол. и психиатр. им. С.С. Корсакова. – 2009. – Т. 109, № 5. – С. 14–19. 2. Максимова Н.Е. Катамнестическое исследование диспансерной когорты психически больных в возрасте старше 60 лет // Казан. мед. журн. – 2006. – № 6. – С. 469–472. 3. Менделевич Б.Д., Куклина А.М. К вопросу о распространенности соматической патологии среди пациентов, страдающих психическими расстройствами // Казан. мед. журн. – 2012. – № 3. – С. 532–534. 4. Brown S. Excess mortality of schizophrenia. A meta-analysis // Br. J. Psychiatry. – 1997. – Vol. 171. – P. 502–508. 5. Brown S., Inskip H., Barracloungh B. Causes of the excess mortality of schizophrenia // Br. J. Psychiatry. – 2000. – Vol. 177. – P. 212–217. 6. Bushe C., Taylor M., Haukka J. Mortality in schizophrenia – A measurable clinical endpoint // J. Psychopharmacol. – 2010. – Vol. 24 (Suppl. 4). – P. 17–25. 7. De Hert M., Dekker J.M., Wood D. et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and European Society of Cardiology (ESC) // Eur. Psychiatry. – 2009. – Vol. 24, N 6. – P. 412–424. 8. Fors B.M., Isacson D., Bingefors K., Widerlov B. Mortality among persons with schizophrenia in Sweden: an epidemiological study // Nord. J. Psychiatry. – 2007. – Vol. 61. – P. 252–259. 9. Harris E.C., Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis // Br. J. Psychiatry. – 1997. – Vol. 170. – P. 205–228. 10. Killian J.G., Kerr K., Lawrence C. et al. Myocarditis and cardiomyopathy associated with clozapine // Lancet. – 1999. – Vol. 354. – P. 1841–1845. 11. Laursen T.M., Nordentoft M. Heart disease treatment and mortality in schizophrenia and bipolar disorder changes in the Danish population between 1994 and 2006 // J. Psychiatr. Res. – 2011. – Vol. 45. – P. 29–35. 12. Lawrence D., Kisely S., Pais J. The epidemiology of excess mortality in people with mental illness // Can. J. Psychiatry. – 2010. – Vol. 55, N 12. – P. 752–759. 13. Osby U., Correia N., Brandt L. et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden // Psych. Res. – 2000. – Vol. 45. – P. 21-28. 14. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? // Arch. Gen. Psychiatry. – 2007. – Vol. 64. – P. 1123–1131. 15. Tiihonen J., Suokas J.T., Suvisaari J.M. et al. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia // Arch. Gen. Psychiatry. – 2012. – Vol. 69, N 5. – P. 476–483.
DOI: http://dx.doi.org/10.24411/1560-957X-2014-1%25x
Article Metrics
Metrics powered by PLOS ALM